VCL-HB01

BIOLOGICAL2 trials

Sponsors

Vical

Conditions

Genital Herpes Simplex Type 2Herpes Genitalis

Phase 1

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

CompletedNCT02030301

VicalGenital Herpes Simplex Type 2

Start: 2013-12-31End: 2016-02-29Updated: 2019-02-27

Phase 2

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

CompletedNCT02837575

VicalHerpes Genitalis

Start: 2016-09-30End: 2018-12-31Updated: 2019-02-27